Antonio Spadea

3.3k total citations
59 papers, 1.2k citations indexed

About

Antonio Spadea is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Antonio Spadea has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 29 papers in Genetics and 18 papers in Oncology. Recurrent topics in Antonio Spadea's work include Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers) and Acute Lymphoblastic Leukemia research (11 papers). Antonio Spadea is often cited by papers focused on Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers) and Acute Lymphoblastic Leukemia research (11 papers). Antonio Spadea collaborates with scholars based in Italy, Malaysia and United States. Antonio Spadea's co-authors include Roberto Latagliata, Maria Concetta Petti, Giuseppe Avvisati, Franco Mandelli, Livio Pagano, Chiara Cattaneo, Massimo Breccia, Maria Antonietta Aloe Spiriti, Enrico Montefusco and Annamaria Nosari and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Antonio Spadea

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Spadea Italy	18	539	469	319	281	220	59	1.2k
Eliana Zuffa Italy	15	395 0.7×	504 1.1×	218 0.7×	102 0.4×	150 0.7×	43	936
Domenico Pastore Italy	21	582 1.1×	379 0.8×	231 0.7×	216 0.8×	205 0.9×	66	1.3k
G Todeschini Italy	19	391 0.7×	764 1.6×	204 0.6×	87 0.3×	264 1.2×	32	1.6k
Claude‐Eric Bulabois France	18	326 0.6×	331 0.7×	117 0.4×	95 0.3×	222 1.0×	63	956
L Debusscher Belgium	14	450 0.8×	286 0.6×	192 0.6×	201 0.7×	271 1.2×	46	1.0k
Hans‐Heinrich Wolf Germany	20	347 0.6×	427 0.9×	100 0.3×	190 0.7×	480 2.2×	42	1.3k
Bernardino Allione Italy	14	631 1.2×	837 1.8×	150 0.5×	375 1.3×	205 0.9×	39	1.4k
Jaime Pérez de Oteyza Spain	17	423 0.8×	228 0.5×	123 0.4×	127 0.5×	127 0.6×	56	885
Akiyoshi Miwa Japan	14	517 1.0×	402 0.9×	175 0.5×	319 1.1×	202 0.9×	79	1.1k
Erika Borlenghi Italy	19	491 0.9×	462 1.0×	216 0.7×	119 0.4×	177 0.8×	59	1.2k

Countries citing papers authored by Antonio Spadea

Since Specialization

Citations

This map shows the geographic impact of Antonio Spadea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Spadea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Spadea more than expected).

Fields of papers citing papers by Antonio Spadea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Spadea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Spadea. The network helps show where Antonio Spadea may publish in the future.

Co-authorship network of co-authors of Antonio Spadea

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Spadea. A scholar is included among the top collaborators of Antonio Spadea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Spadea. Antonio Spadea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Molica, Matteo, Carla Mazzone, Pasquale Niscola, et al.. (2022). Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience. Cancers. 14(19). 4897–4897. 6 indexed citations

Mazzucconi, Maria Gabriella, Roberto Latagliata, Massimo Breccia, et al.. (2020). Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the “Ph1‐negative Myeloproliferative Neoplasms Latium Group”. European Journal Of Haematology. 105(3). 335–343. 10 indexed citations

Marchesi, Francesco, Saveria Capria, Diana Giannarelli, et al.. (2018). BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant. Bone Marrow Transplantation. 53(8). 1051–1054. 3 indexed citations

Breccia, Massimo, Alessandro Andriani, Marco Montanaro, et al.. (2016). Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN. Annals of Hematology. 96(3). 387–391. 13 indexed citations

Marchesi, Francesco, Daniela Renzi, Francesca Palombi, et al.. (2015). Biosimilar filgrastim (Zarzio^®) vs. lenograstim (Myelostim^®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience. Leukemia & lymphoma. 57(2). 489–492. 8 indexed citations

Pagano, Livio, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.. (2012). Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 98(2). 239–246. 208 indexed citations

Tumbarello, Mario, Enrico Maria Trecarichi, Morena Caira, et al.. (2012). Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality. PLoS ONE. 7(12). e51612–e51612. 23 indexed citations

Marchesi, Francesco, Federica Giannotti, Giuseppe Avvisati, et al.. (2011). The potential role of pre‐transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. American Journal of Hematology. 87(2). 213–217. 11 indexed citations

Chierichini, Anna, Alessandra Spagnoli, Maria Gozzer, et al.. (2010). Standard‐ versus high‐dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization. Transfusion. 50(11). 2432–2446. 8 indexed citations

10.

Latagliata, Roberto, Angela Rago, Antonio Spadea, et al.. (2009). Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results. International Journal of Hematology. 90(4). 486–491. 1 indexed citations

11.

Petti, Maria Concetta, Agostino Tafuri, Roberto Latagliata, et al.. (2003). High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias. Annals of Hematology. 82(8). 476–480. 9 indexed citations

12.

Girmenia, Corrado, Massimo Breccia, Roberto Latagliata, et al.. (2003). Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen. Leukemia. 17(5). 925–930. 35 indexed citations

13.

Montefusco, Enrico, Francesco Fazi, Iole Cordone, et al.. (2001). Molecular Remission Following High-Dose Hydroxyurea and Fludarabine Plus Cytarabine in a Patient with Simultaneous Acute Myeloid Leukemia and Low-Grade Lymphoma. Leukemia & lymphoma. 40(5-6). 671–674. 10 indexed citations

14.

Latagliata, Roberto, Massimo Breccia, Alessandro Pulsoni, et al.. (2000). Acute Myeloblastic Leukemia Secondary to Myelodysplasia (MDS-AML): A Comparison of Remission Induction with Three Drugs Versus Standard Two-Drugs Induction. Leukemia & lymphoma. 36(5-6). 539–541. 1 indexed citations

15.

Latagliata, Roberto, Giuseppe Avvisati, Maria Concetta Petti, et al.. (1997). The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged >60 years. Annals of Oncology. 8(12). 1273–1275. 23 indexed citations

16.

Venuta, Federico, Erino Angelo Rendina, Edoardo Pescarmona, et al.. (1997). Salvage Lung Resection for Massive Hemoptysis after Resolution of Pulmonary Aspergillosis in a Patient with Acute Leukemia. Scandinavian Cardiovascular Journal. 31(1). 51–53. 1 indexed citations

17.

Petti, Maria Concetta, Roberto Latagliata, Giuseppe Avvisati, et al.. (1996). Treatment of high‐risk myelodysplastic syndromes with lymphoblastoid alpha interferon. British Journal of Haematology. 95(2). 364–367. 8 indexed citations

18.

Spiriti, Maria Antonietta Aloe, et al.. (1993). Recombinant human erythropoietin in the treatment of myelodysplastic syndromes. An interim report.. PubMed. 78(2). 123–6. 5 indexed citations

19.

Spiriti, Maria Antonietta Aloe, Maria Concetta Petti, Roberto Latagliata, et al.. (1993). Is Recombinant Human Erythropoietin Treatment in Myelodysplastic Syndromes Worthwhile?. Leukemia & lymphoma. 9(1-2). 79–83. 15 indexed citations

20.

Avvisati, Giuseppe, Franco Mandelli, Maria Concetta Petti, et al.. (1990). Idarubicin (4‐demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: A pilot study of the Italian cooperative group GIMEMA. European Journal Of Haematology. 44(4). 257–260. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact